Likewise, ZM447439, an Aurora kinase inhibitor, has shown effective inhibition of both AURKA and AURKB activities via reduction in histone H3 phosphorylation, resulting in decreased cell growth in mesothelioma cell lines [48]. Here, AURKB is linked to mesothelioma.